Fig. 1: The main TKI drugs on the market in recent 20 years.
From: Current progress and open challenges for applying tyrosine kinase inhibitors in osteosarcoma
The main TKIs approved in chronological order by China’s National Medical Products Administration, Japan’s Ministry of Health, Labour and Welfare and the US Food and Drug Administration in recent years.
